Rimeporide in Duchenne presented at the 5th Myology Congress
12Mar
EspeRare will present a poster on the "Translational Development of Rimeporide, a Sodium-Hydrogen Exchanger (NHE-1) Inhibitor, as a therapy for Patients with Duchenne Muscular Dystrophy" at the 5th Myology International Confenrence in Lyon from 14th to 18th March 2016.
Click on picture to view
For more information on the Myology Congress click here